Organogenesis Holdings Inc
ORGO
NASDAQ
Biotechnology
$1.79
USD
+0.03 (+1.70%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $230.97M
Volume 547.6K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics Inc | $240.97M | - | +7.5% | - | |
TARA | Protara Therapeutics Inc | $233.72M | - | - | - | |
ORGO | Organogenesis Holdings Inc | $230.97M | 84.95 | +12.2% | - | |
ALEC | Alector Inc | $227.22M | - | -79.2% | - | |
IMUX | Immunic Inc | $225.34M | - | - | - | |
ARCT | Arcturus Therapeutics Holdings Inc | $222.41M | - | -76.0% | - | |
NBP | NovaBridge Biosciences | $219.23M | - | - | - | |
RNA | Atrium Therapeutics Inc | $209.37M | - | +22.0% | - | |
CNXU | Conexeu Sciences Inc | $194.53M | - | - | - | |
NERV | Minerva Neurosciences Inc | $187.17M | - | - | - |
Top Peer by Growth
Atrium Therapeutics Inc
+22.0% YoY Revenue
Lowest P/E Ratio
Organogenesis Holdings Inc
84.95x P/E
Best 1-Year Return
Minerva Neurosciences Inc
+116.6% Return